SCHEMBL31240753

SCHEMBL31240753

Cc1ccc(S(=O)(=O)Nc2cccc(-c3cc4c(Cl)ccnc4[nH]3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIT P10721 3/20 0.50
▸ SYK P43405 2/20 0.48
▸ POLB P06746 1/20 0.47
▸ CHUK O15111 1/20 0.47
▸ INSR P06213 1/20 0.47
▸ MAPK8 P45983 1/20 0.47
▸ CAMKK2 Q96RR4 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ SLC40A1 Q9NP59 1/20 0.46
▸ BRAF P15056 2/20 0.46
▸ TNNI3K Q59H18 2/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ ADAM17 P78536 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ KLF5 Q13887 1/20 0.45
▸ LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240542 0.89 KIT (0.62) KITPOLBCHUKINSRMAPK8
SCHEMBL31240646 0.84 CHUK (0.62) KITCHUKINSRMAPK8CAMKK2
SCHEMBL31240667 0.78 CDK9 (0.46) KITSYKCHUKINSRMAPK8
SCHEMBL31240599 0.78 CHUK (0.51) KITCHUKINSRMAPK8CAMKK2
SCHEMBL15664354 0.75 KIT (0.84) KIT
SCHEMBL31240593 0.72 CDC7 (0.59) ALDH1A1MAPTMEN1NPC1RAB9A
SCHEMBL16041244 0.72 CDC7 (0.59) ALDH1A1MAPTMEN1NPC1RAB9A
SCHEMBL14877794 0.71 CA12 (0.76) POLBALDH1A1MEN1KMT2ALMNA
SCHEMBL31240751 0.71 CCNB2 (0.61) CDK1CCNB1
SCHEMBL31240688 0.71 CDK9 (0.50) MEN1CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback